NEOGEN CHEMICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,464 INR | -3.71% |
|
-5.08% | -1.07% |
| 05-02 | Transcript : Neogen Chemicals Limited, Q4 2024 Earnings Call, May 02, 2024 | |
| 04-30 | Neogen Chemicals Limited Recommends Final Dividend for the Financial Year 2023-2024 | CI |
Valuation
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 7,961 | 20,086 | 43,504 | 32,077 | 38,628 | - | - |
| Enterprise Value (EV) 1 | 7,961 | 22,093 | 45,029 | 35,565 | 31,558 | 46,573 | 38,628 |
| P/E ratio | - | 64 x | 93.3 x | 64.2 x | 85.7 x | 48.2 x | 37.6 x |
| Yield | 0.59% | 0.26% | 0.16% | 0.23% | 0.23% | 0.21% | 0.24% |
| Capitalization / Revenue | 2.6 x | 5.97 x | 8.93 x | 4.67 x | 4.57 x | 3.98 x | 2.73 x |
| EV / Revenue | 2.6 x | 6.57 x | 9.24 x | 5.18 x | 4.57 x | 4.8 x | 2.73 x |
| EV / EBITDA | 13.7 x | 34.1 x | 52 x | 31.8 x | 28.7 x | 29.4 x | 16.1 x |
| EV / FCF | -12.6 x | 36.5 x | -69.5 x | -26.8 x | -26.2 x | -12.4 x | - |
| FCF Yield | -7.96% | 2.74% | -1.44% | -3.74% | -3.81% | -8.04% | - |
| Price to Book | - | 11 x | 9.9 x | 6.65 x | 5.68 x | 4.94 x | 4.21 x |
| Nbr of stocks (in thousands) | 23,335 | 23,335 | 24,939 | 24,939 | 26,382 | - | - |
| Reference price 2 | 341.2 | 860.8 | 1,744 | 1,286 | 1,464 | 1,464 | 1,464 |
| Announcement Date | 23/05/20 | 29/05/21 | 14/05/22 | 13/05/23 | 30/04/24 | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 2,391 | 3,061 | 3,364 | 4,872 | 6,862 | 6,907 | 9,695 | 14,159 |
| EBITDA 1 | - | 581.6 | 647.5 | 865.9 | 1,117 | 1,100 | 1,583 | 2,403 |
| EBIT 1 | - | - | 578.5 | 749 | 955.2 | 871.8 | 1,354 | 2,067 |
| Operating Margin | - | - | 17.19% | 15.37% | 13.92% | 12.62% | 13.97% | 14.6% |
| Earnings before Tax (EBT) 1 | - | - | 442.2 | 570.7 | 710.3 | 527.7 | 946.6 | 1,358 |
| Net income 1 | - | - | 313.3 | 446.3 | 499.7 | 356.5 | 765.2 | 1,027 |
| Net margin | - | - | 9.31% | 9.16% | 7.28% | 5.16% | 7.89% | 7.25% |
| EPS 2 | - | - | 13.45 | 18.70 | 20.03 | 13.96 | 30.37 | 38.93 |
| Free Cash Flow 1 | - | -633.8 | 605.1 | -648.3 | -1,328 | -1,676 | -3,744 | - |
| FCF margin | - | -20.7% | 17.99% | -13.31% | -19.36% | -23.2% | -38.62% | - |
| FCF Conversion (EBITDA) | - | - | 93.46% | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | 193.14% | - | - | - | - | - |
| Dividend per Share 2 | - | 2.000 | 2.250 | 2.750 | 3.000 | 3.350 | 3.067 | 3.500 |
| Announcement Date | 25/05/19 | 23/05/20 | 29/05/21 | 14/05/22 | 13/05/23 | 30/04/24 | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2021 S1 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,585 | 852.1 | 927 | 846.4 | - | 1,327 | 1,568 | 1,479 | 1,481 | 1,862 | 1,649 | 1,645 | 1,759 | 1,876 |
| EBITDA 1 | 292.4 | 169.3 | 185.7 | 156.6 | - | 238 | 266.2 | 264.9 | - | - | 280.8 | 264.7 | 283 | 279.7 |
| EBIT | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net income | - | - | - | 73.56 | 111.7 | - | 156.4 | 111 | - | - | - | 95 | 108 | 91.5 |
| Net margin | - | - | - | 8.69% | - | - | 9.97% | 7.51% | - | - | - | 5.78% | 6.14% | 4.88% |
| EPS | - | - | - | - | 4.790 | - | - | - | - | - | - | 3.450 | 3.100 | 3.000 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 07/11/20 | 13/02/21 | 29/05/21 | 07/08/21 | 30/10/21 | 29/01/22 | 14/05/22 | 06/08/22 | 05/11/22 | 11/02/23 | 05/08/23 | - | - | - |
1INR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 2,007 | 1,525 | 3,488 | 5,325 | 7,945 | - |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | 3.099 x | 1.761 x | 3.122 x | 4.778 x | 5.02 x | - |
| Free Cash Flow 1 | - | -634 | 605 | -648 | -1,328 | -1,676 | -3,744 | - |
| ROE (net income / shareholders' equity) | - | 25.3% | 18.5% | 14.3% | 10.8% | 7.28% | 10.6% | 11.9% |
| ROA (Net income/ Total Assets) | - | - | - | 6.91% | 5.39% | - | - | - |
| Assets 1 | - | - | - | 6,456 | 9,266 | - | - | - |
| Book Value Per Share 2 | - | - | 78.40 | 176.0 | 193.0 | 258.0 | 297.0 | 348.0 |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | - | 288 | 231 | 662 | 1,025 | 2,000 | 3,615 | 1,500 |
| Capex / Sales | - | 9.42% | 6.85% | 13.59% | 14.94% | 27.68% | 37.28% | 10.59% |
| Announcement Date | 25/05/19 | 23/05/20 | 29/05/21 | 14/05/22 | 13/05/23 | 30/04/24 | - | - |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
1,464
INR
Average target price
1,759
INR
Spread / Average Target
+20.13%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.07% | 481M | |
| +17.76% | 66.6B | |
| +0.84% | 48.75B | |
| +17.11% | 41.45B | |
| +20.06% | 26.74B | |
| +11.45% | 19.55B | |
| +3.89% | 18.21B | |
| -21.31% | 16.02B | |
| +3.82% | 15.62B | |
| -7.57% | 15.33B |
- Stock Market
- Equities
- NEOGEN Stock
- Financials Neogen Chemicals Limited
